Introduction
Seasonal influenza is estimated to cause between 1-4 million cases of severe illness and 200,000 to 500,000 deaths per year 1 . The best way to protect against influenza infection is through vaccination. Currently, a trivalent (TIV) or quadravalent influenza (QIV) vaccine is given each year, targeting the circulating H1N1 and H3N2 influenza A strains and one or two lineages of the circulating influenza B strains. However, the vaccine has to be formulated at least 6 months prior to the influenza season and so the strains that are subsequently prevalent in the actual flu season do not always match the strains used in the vaccine 2 .
The antigenic evolution of influenza is known to occur through mutations in surface glycoproteins, principally haemagglutinin (HA), allowing strains to escape pre-existing host immunity [3] [4] [5] . Epitopes within HA are commonly assumed to be either highly variable due to strong immune selection (and typically located in the head domain of HA) or conserved due to the absence of immune selection (for example, in the stalk of HA) 6 . Together, these form the backbone of the theory of 'antigenic drift' whereby the virus population slowly and incrementally acquires mutations in protective highly variable epitopes. However, the antigenic drift model can only explain the epidemiology and limited genetic diversity observed among influenza virus populations when very specific constraints are placed on the mode and tempo of mutation or by invoking short-term strain-transcending immunity 7, 8 . An alternative model known as 'antigenic thrift' successfully models the epidemiology and genetic diversity of influenza by assuming that immune responses against epitopes of limited variability drive the antigenic evolution of influenza [9] [10] [11] . Within this framework, new strains may be generated constantly through mutation but most of these cannot expand in the host population due to pre-existing immune responses against epitopes of limited variability. This creates the conditions for the sequential appearance of antigenically distinct strains and provides a solution to the longstanding conundrum of why the virus population exhibits such limited antigenic and genetic diversity within an influenza epidemic. An important translational corollary of this model is that a 'universal' influenza vaccine may be constructed by targeting such protective epitopes of limited variability.
We show that studies of sera from young children taken in 2006/7 using neutralisation assays and ELISAs reveals a periodic pattern of cross-reactivity to historical isolates consistent with the recycling of epitopes of limited variablity. We idenfity one epitope of limited variability 
Results

Recognition of historical isolates follows a pattern consistent with recycling of epitopes
We tested the prediction that HA epitopes of limited variability exist by performing microneutralisation assays using pseudotyped lentiviruses displaying the H1 HA proteins from a panel of historical influenza isolates (hereafter described as pMN assays 12, 13 A/South Carolina/1/1918 strains respectively. ELISA analysis using the HA1 domain of the same seven strains as an antigen was consistent with the pMN data and also identified broadly cross-reactive non-neutralising antibodies that bind the HA HA1 region of various H1 influenza strains ( Fig S1A) . These results are in agreement with number of recent studies suggesting antibody responses show some degree of periodic cross-reactivity to historical strains [14] [15] [16] [17] [18] [19] [20] [21] [22] counter to the view of 'antigenic drift' within which antigenic distance accumulates linearly with time. Analysis of historical strain data shows that the deletion, the only one to occur in the H1 HA, Analysis of this site (hereafter called 'OREO') suggested that various conformational epitope variants could be defined on the basis of variation and structural proximity of positions 147, 158 and 159. Combining these analyses with the site directed mutagenesis SDM results, we arrived at a maximum of five epitope conformations of the epitope (Figs 3 & S3) , which arise and disappear in a cyclical manner during the known evolutionary history of the pre-pandemic and post-pandemic H1N1 lineages (Fig 2D) . This analysis demonstrates that there are numerous sites of limited variability in the head domain of the H1 HA, in addition to a range of highly variable sites (Fig 2A) ; the antigenic trajectory of the latter has been tracked in detail by several previous studies 32, 33 . showed periodic cross-reactivity to historical strains demonstrating the chronological reoccurrence of epitopes of limited variability (Fig 4B-G) . 
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Discussion
Our results demonstrate the existence of a highly immunogenic epitope of limited variability in the head domain of the H1 HA, which have been theorised by mathematical modelling studies to drive the antigenic evolution of influenza 9, 10 . Sera from children aged 6-12 years taken in 2006/7 was shown to cross-react with a panel of historical isolates, the majority of which they will not have experienced (Fig 1A) . This cross-reactivity was removed by mutagenesis of an epitope of Serum or plasma was diluted in casein-PBS solution at dilutions ranging from 1:50 to 1:1000, before being added to Nunc-Immuno 96 well plates in triplicate. Plates were incubated at 4°C overnight before being washed as previously described. Secondary antibody rabbit anti-human whole IgG conjugated to alkaline phosphatase, Sigma was added at a dilution of 1:3000 in casein-PBS solution and incubated for 1.5 hours at RT. After a final wash, plates were developed by adding 4-nitrophenyl phosphate substrate in diethanolamine buffer Pierce, Loughborough, UK and optical density OD was read at 405nm using an ELx800 microplate reader Cole Parmer, London, UK. A reference standard comprising of pooled cross-reactive serum and naïve serum on each plate served as a positive and negative control respectively. Data is presented as arbitrary units determined using the NIH standard calculator based on subtraction of background from samples and interpolation from the standard curve using a 4 parameter fit model 35 .
A positive reference standard was used on each plate to produce a standard curve. given amino acid and all others within a structure. Those residues whose α carbon sequences were within the specified area were recorded and used to produce disrupted peptide sequences for a given binding site. Antibody binding site variability was calculated as the mean pairwise hamming distance between the consensus sequences collected between 1918 to 2016. The sequences were aligned using MUSCLE before being manually curated using AliView. 
Vaccination of mice:
Statistical analysis
Student's t-tests were performed to determine all p-values shown in Figure 1 .
Area under the curve was calculated for the mouse weight loss data ( Fig 5A&C, main text) , and analysed in a single-factor ANOVA. Between-group comparisons were then performed using Tukey's post hoc method for pairwise comparison correction to provide corrected p-values.
Fisher's Exact test was used to determine survival differences in the experimental groups after seven days (Fig 5B&D) . All p-values were adjusted to multiple comparisons using the Bonferroni-Holm correction.
Phylogenetic analysis
RAxML version 8.2.11 was used to build a maximum likelihood tree based on the strain HA amino acid sequences, using a gamma distributed site heterogeneity model and the amino acid FLU substitution model. Tip-to-root distance was regressed against sequence dates, using a best fitting root, in Tempest V1.5. Accession numbers can be found in the supplementary material. Figure S1 . ELISA analysis of sera from children aged 6 to 12 years and 12 to 18 months using the HA1 domain of a number of chronologically dispersed strains. Figure S2 . Variation in antibody binding sites mapped onto the surface of various H1 HA crystal structures. Figure S3 . Identification of the various conformations of a site of limited variability in the head domain of the H1 HA through structural bioinformatic analysis. Table S1 : Sequences cloned into H6, H5 and H11 HAs. Table S2 : Accession numbers pre-2009 pandemic Table S3 : Accession numbers post-2009 pandemic
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A.
B. Figure S1 . ELISA analysis of sera from children aged 6 to 12 years and 12 to 18 months using the HA1 domain of a number of chronologically dispersed strains. A. ELISA analysis of sera from children aged 6 to 12 years. B. ELISA analysis of sera from children aged 12 to 18 months. The HA1 domain of a number of chronologically dispersed strains was used as an antigen. All ELISAs were standardised using positive sera. Samples were either allocated as 'positive' (red) or 'negative' (white) based on whether they fell into the linear range of the standard curve. The percentage of the samples that displayed reactivity to each strain is provided on the right hand side of the figure. Centroid of antibiody binding site Mean Hamming distance
